NCT07216261

Brief Summary

Implementing Cognitive Behavioral Therapy for Insomnia with Older Veterans (SWELL): Function QUERI 3.0 aims to compare implementation approaches while also gathering information on clinical effectiveness of the EBP in its new context. The overall goal is to address a key priority within the implementation science field - identifying and refining metrics for equity and impact. The overall goal is to implement, evaluate, and sustain SWELL in 20 VA facilities using a type III effectiveness-implementation hybrid study framework and parallel CRT design.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
49mo left

Started Oct 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 14, 2025

Completed
12 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2030

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2030

Last Updated

October 14, 2025

Status Verified

October 1, 2025

Enrollment Period

4 years

First QC Date

October 2, 2025

Last Update Submit

October 8, 2025

Conditions

Keywords

Sleep DisordersImplementation ScienceFunctional StatusQuality of LifeCognitive Behavioral TherapyVeterans

Outcome Measures

Primary Outcomes (1)

  • Reach

    Reach (primary) will be defined as the number of older Veterans who initiate SWELL at six, 12, and 18 (primary) months.

    18 months

Secondary Outcomes (2)

  • Fidelity

    18 months

  • Adoption

    18 months

Other Outcomes (3)

  • Cost of Treatment

    18 months

  • Insomnia Severity

    Baseline

  • Insomnia Severity

    6 weeks

Study Arms (2)

Foundational Support

ACTIVE COMPARATOR

Foundational Support uses the Replicating Effective Program (REP) implementation strategy and includes 5 elements that were developed and tested in our prior Function QUERI work: shareholder engagement, SWELL toolkit, online shared resources (SharePoint) access for clinical program training materials, data reports to assist sites with tracking their data, and Diffusion Networks to promote peer-to-peer sharing and implementation support.

Other: Implementation Strategy: Foundational Support

Reach+Equity Bundle

EXPERIMENTAL

The Reach+Equity bundle will include the same activities as foundational support plus the Reach+Equity bundle activities which include: 1) external facilitation (designed to provide an outside perspective to help sites identify barriers, develop effective strategies, and navigate complex change processes particularly through the lens of achieving equitable reach); 2) equity in implementation toolkit (guide that supports awareness and consideration of equitable program reach and delivery during the implementation process); and 3) equity-focused data-driven monitoring (inform progress regarding equitable reach-related goals).

Other: Implementation Strategy: Reach+Equity Bundle

Interventions

The primary goal of SWELL is to compare implementation approaches while also gathering information on clinical effectiveness of the EBP in its new context. All sites will be randomized to receive 1) foundational REP implementation support alone or 2) foundational REP and Reach+Equity. We propose that low intensity implementation support that promotes engagement with SWELL (defined as foundational support), will be sufficient for some but not all facilities to successfully incorporate SWELL into routine practice.

Also known as: Foundational REP
Foundational Support

We hypothesize that adding the Reach+Equity bundle to foundational REP, compared to foundational REP alone, will result in superior implementation outcomes.

Also known as: Enhanced Support
Reach+Equity Bundle

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • meet diagnostic criteria for chronic insomnia disorder (with or without documented diagnosis)
  • absence of a CBTI contraindication
  • i.e., comorbid condition that makes CBTI unsafe), including uncontrolled seizure disorders, bipolar disorder I, and/or too medically or psychiatrically unstable to engage in a multi-session treatment
  • patients can be referred to SWELL by a clinician or self-referred

You may not qualify if:

  • younger than 60
  • do not meet criteria for enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Durham VA Medical Center, Durham, NC

Durham, North Carolina, 27705-3875, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersSleep Wake Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasNervous System DiseasesMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jaime Hughes, PhD

    Durham VA Medical Center, Durham, NC

    PRINCIPAL INVESTIGATOR
  • Jennifer L Martin, PhD

    VA Greater Los Angeles Healthcare System, Sepulveda, CA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Caitlin B Kappler, MSW

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Parallel cluster-randomized trial (parallel-CRT): used in pragmatic evaluations of health program or policy interventions, where half the clusters (in this case, VA sites) are randomly assigned to one of two interventions: Foundational support only (active comparator) vs. Foundational support plus Reach+Equity Implementation Bundle (experimental).
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2025

First Posted

October 14, 2025

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

September 30, 2030

Study Completion (Estimated)

September 30, 2030

Last Updated

October 14, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

A de-identified, anonymized dataset will be available upon request. Prior to distribution, a local privacy officer and study statistician will certify that the dataset contains no protected health information (PHI). Data will be provided to requestor in electronic format. Sufficient data and descriptors will be made available to duplicate statistical analysis and confirm conclusions in publication. No data or statistical code that could lead to re-identification of individuals will be released. Data will be stored \& maintained in an approved, secured location as described in the VA Research Data Inventory Form. The statistician will create de-identified, publication-specific datasets that includes variables from statistical models presented in publication. Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re-identify any individual whose data are included in the dataset.

Shared Documents
STUDY PROTOCOL
Time Frame
Available upon request.
Access Criteria
Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re- identify any individual whose data are included in the dataset.
More information

Locations